Omalizumab: new addition to dermatologic therapy for chronic spontaneous/idiopathic urticaria. J Pak Assoc Dermatol [Internet]. 2016 Nov. 26 [cited 2026 Jul. 26];25(4):249-51. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/139